ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2905

The IL-6/Th17 Axis Promotes Autoantibody-Associated Autoimmune Valvular Carditis in Mice

Jennifer L. Auger1, Brianna J. Engelson2, Yaya Wang3, Erik J. Peterson4 and Bryce A. Binstadt5, 1Center for Immunology and Department of Pediatrics, University of Minnesota, Minneapolis, MN, 2Pediatrics, University of Minnesota, Minneapolis, MN, 3Medicine, University of Minnesota, Minneapolis, MN, 4University of Minnesota, Minneapolis, MN, 5Pediatric Rheumatology, University of Minnesota, Minneapolis, MN

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Animal models, Heart disease, IL-6, macrophages and rheumatoid arthritis, T cells

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Autoimmune valvular carditis occurs in patients with systemic lupus erythematosus, rheumatoid arthritis and rheumatic fever, but the pathogenic mechanisms remain incompletely defined. Spontaneous autoimmune valvular carditis develops in the K/BxN T cell receptor transgenic mouse model of autoantibody-dependent inflammatory arthritis.  CD4 T helper (Th) cells and macrophages cooperate to promote carditis in this model. We investigated which effector Th cell population was the predominant driver of cardiovascular pathology in K/BxN mice.

Methods:

We first used RT-PCR to measure key cytokine transcript levels in cardiac valves of arthritic K/BxN mice and controls.  We then used anti-cytokine blocking antibodies and gene knockout mice to determine which Th effector cells and cytokines were most critical for valve inflammation.

Results:

We found increased expression of the genes encoding the Th17 differentiation factor IL-6 and IL-17A itself in K/BxN mitral valves relative to controls; IL-4 and IFNγ transcript levels were not different.  Antibody blockade of IL-6 or IL-17A reduced the severity of valve inflammation, whereas blocking IL-4 had no effect.  Genetic deficiency of IFNγ did not affect carditis severity.  K/BxN mice lacking the key Th17 transcription factor RORγt had delayed onset of arthritis and were protected from valvular carditis.

Conclusion:

Th17 cells are key drivers of autoimmune valvular carditis in K/BxN mice. We suggest a model in which autoantibodies engage Fc receptors on macrophages, leading to IL-6 production, which in turn promotes the differentiation of valve-infiltrating Th17 effector cells.  Our results provide new insight into the mechanisms of valvular carditis in systemic autoantibody-mediated rheumatic diseases.  More broadly, these findings may help guide the selection of therapies to reduce cardiovascular morbidity and mortality among patients with rheumatoid arthritis and systemic lupus erythematosus.


Disclosure:

J. L. Auger,
None;

B. J. Engelson,
None;

Y. Wang,
None;

E. J. Peterson,
None;

B. A. Binstadt,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2014

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-il-6th17-axis-promotes-autoantibody-associated-autoimmune-valvular-carditis-in-mice/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology